Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 203

1.

Bilateral patellar fractures and increased cortical bone thickness associated with long-term oral alendronate treatment in a cat.

Council N, Dyce J, Drost WT, de Brito Galvao JF, Rosol TJ, Chew DJ.

JFMS Open Rep. 2017 Aug 29;3(2):2055116917727137. doi: 10.1177/2055116917727137. eCollection 2017 Jul-Dec.

2.

Atypical fracture with long-term bisphosphonate therapy is associated with altered cortical composition and reduced fracture resistance.

Lloyd AA, Gludovatz B, Riedel C, Luengo EA, Saiyed R, Marty E, Lorich DG, Lane JM, Ritchie RO, Busse B, Donnelly E.

Proc Natl Acad Sci U S A. 2017 Aug 15;114(33):8722-8727. doi: 10.1073/pnas.1704460114. Epub 2017 Jul 31.

3.

Lateral Femoral Bowing and the Location of Atypical Femoral Fractures.

Yoo H, Cho Y, Park Y, Ha S.

Hip Pelvis. 2017 Jun;29(2):127-132. doi: 10.5371/hp.2017.29.2.127. Epub 2017 Jun 2.

4.

Long-term use of bisphosphonates in osteoporosis.

Alwahhabi BK, Alsuwaine BA.

Saudi Med J. 2017 Jun;38(6):604-608. doi: 10.15537/smj.2017.6.19793.

5.

Sanguinarine protects against ovariectomy‑induced osteoporosis in mice.

Ma Y, Chu J, Ma J, Ning L, Zhou K, Fang X.

Mol Med Rep. 2017 Jul;16(1):288-294. doi: 10.3892/mmr.2017.6574. Epub 2017 May 11.

6.

Atypical Femoral Shaft Fractures in Female Bisphosphonate Users Were Associated with an Increased Anterolateral Femoral Bow and a Thicker Lateral Cortex: A Case-Control Study.

Jang SP, Yeo I, So SY, Kim K, Moon YW, Park YS, Lim SJ.

Biomed Res Int. 2017;2017:5932496. doi: 10.1155/2017/5932496. Epub 2017 Mar 28.

7.

Spinal Compression Fracture Management: A Review of Current Treatment Strategies and Possible Future Avenues.

Genev IK, Tobin MK, Zaidi SP, Khan SR, Amirouche FML, Mehta AI.

Global Spine J. 2017 Feb;7(1):71-82. doi: 10.1055/s-0036-1583288. Epub 2017 Feb 1. Review.

8.

Elevation of pro-inflammatory cytokine levels following anti-resorptive drug treatment is required for osteonecrosis development in infectious osteomyelitis.

Morita M, Iwasaki R, Sato Y, Kobayashi T, Watanabe R, Oike T, Nakamura S, Keneko Y, Miyamoto K, Ishihara K, Iwakura Y, Ishii K, Matsumoto M, Nakamura M, Kawana H, Nakagawa T, Miyamoto T.

Sci Rep. 2017 Apr 7;7:46322. doi: 10.1038/srep46322.

9.

A new contralateral atypical femoral fracture despite sequential therapy with teriparatide and strontium ranelate.

Nguyen HH, Milat F, Ebeling PR.

Bone Rep. 2017 Jan 7;6:34-37. doi: 10.1016/j.bonr.2017.01.002. eCollection 2017 Jun.

10.

Proximal femoral reconstruction for failed internal fixation of a bisphosphonate-related femur fracture.

Jethanandani RG, Nwankwo C, Wolinsky PR, Giordani M, Amanatullah DF.

Arthroplast Today. 2016 Aug 24;2(4):153-156. doi: 10.1016/j.artd.2016.04.001. eCollection 2016 Dec.

11.

Bisphosphonates and atypical subtrochanteric fractures of the femur.

Kharwadkar N, Mayne B, Lawrence JE, Khanduja V.

Bone Joint Res. 2017 Mar;6(3):144-153. doi: 10.1302/2046-3758.63.BJR-2016-0125.R1.

12.

Long-term effects of bisphosphonate therapy: perforations, microcracks and mechanical properties.

Ma S, Goh EL, Jin A, Bhattacharya R, Boughton OR, Patel B, Karunaratne A, Vo NT, Atwood R, Cobb JP, Hansen U, Abel RL.

Sci Rep. 2017 Mar 6;7:43399. doi: 10.1038/srep43399.

13.

Atypical periprosthetic acetabular fracture in long-term alendronate therapy.

Marongiu G, Capone A.

Clin Cases Miner Bone Metab. 2016 Sep-Dec;13(3):209-213. doi: 10.11138/ccmbm/2016.13.3.209. Epub 2017 Feb 10.

14.

"Atypical" atypical femur fractures and use of bisphosphonates.

van de Laarschot DM, Somford MP, Jager A, Oei EH, Bos PK, Zillikens MC.

Clin Cases Miner Bone Metab. 2016 Sep-Dec;13(3):204-208. doi: 10.11138/ccmbm/2016.13.3.204. Epub 2017 Feb 10.

15.

Atypical femoral shaft fractures secondary to long-term bisphosphonate therapy.

Kayali C, Altay T, Ozan F, Sozkesen S, Yamak K.

J Orthop. 2017 Feb 3;14(2):226-230. doi: 10.1016/j.jor.2017.01.002. eCollection 2017 Jun.

PMID:
28203048
16.

Dental extraction following zoledronate, induces osteonecrosis in rat's jaw.

Vidal-Gutiérrez X, Gómez-Clavel JF, Gaitán-Cepeda LA.

Med Oral Patol Oral Cir Bucal. 2017 Mar 1;22(2):e177-e184.

17.

Skeletal Site-specific Effects of Zoledronate on in vivo Bone Remodeling and in vitro BMSCs Osteogenic Activity.

Gong X, Yu W, Zhao H, Su J, Sheng Q.

Sci Rep. 2017 Jan 31;7:36129. doi: 10.1038/srep36129.

18.

Intrinsic material property differences in bone tissue from patients suffering low-trauma osteoporotic fractures, compared to matched non-fracturing women.

Vennin S, Desyatova A, Turner JA, Watson PA, Lappe JM, Recker RR, Akhter MP.

Bone. 2017 Apr;97:233-242. doi: 10.1016/j.bone.2017.01.031. Epub 2017 Jan 27.

PMID:
28132909
19.

Complex regional pain syndrome: a recent update.

Goh EL, Chidambaram S, Ma D.

Burns Trauma. 2017 Jan 19;5:2. doi: 10.1186/s41038-016-0066-4. eCollection 2017. Review.

20.

Incidence and medical management of bisphosphonate-associated atypical femoral fractures in a major trauma centre: a retrospective observational study.

Eisenstein N, Kasavkar G, Bhavsar D, Khan FS, Paskins Z.

BMC Musculoskelet Disord. 2017 Jan 23;18(1):29. doi: 10.1186/s12891-017-1392-9.

Supplemental Content

Support Center